AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28624750 — intervention group
Group type: EXPERIMENTAL
Intervention: Air filtration intervention
Number of subjects: 200
Study 28624750 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 200
Study 25503599 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) coping skills training
Number of subjects: 46
Study 25503599 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) skills use
Number of subjects: 46
Study 25503599 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 46
Study 23240643 — intervention group
Group type: EXPERIMENTAL
Intervention: Manidipine 20 mg
Number of subjects: 104
Study 23240643 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 104
Study 21325105 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (500 mg vitamin C and 400 IU vitamin E daily)
Number of subjects: 21
Study 21325105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 19893971 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma Desensitizer (GD)
Number of subjects: 101
Study 19893971 — intervention group
Group type: EXPERIMENTAL
Intervention: Seal& (SP)
Number of subjects: 101
Study 19893971 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxa-gel (OG)
Number of subjects: 101
Study 19893971 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride (F)
Number of subjects: 101
Study 19893971 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity laser-LILT (660 nm/3.8 J/cm(2)/15 mW)
Number of subjects: 101
Study 16899098 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth brushing and inter‐dental flossing
Number of subjects: 19
Study 16899098 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth brushing and tongue scraping
Number of subjects: 19
Study 16899098 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth brushing, inter‐dental flossing and tongue scraping
Number of subjects: 19
Study 16899098 — intervention group
Group type: COMPARATOR
Intervention: Tooth brushing
Number of subjects: 19
Study 16946177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranylcypromine
Number of subjects: 109
Study 16946177 — intervention group
Group type: COMPARATOR
Intervention: Extended-release venlafaxine plus mirtazapine
Number of subjects: 109
Study 14570856 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of the MR agonist fludrocortisone
Number of subjects: 20
Study 14570856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11789203 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiongshao capsule (XSC)
Number of subjects: 65
Study 11789203 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine treatment plus XSC
Number of subjects: 65
Study 11789203 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 65
Study 8887014 — intervention group
Group type: EXPERIMENTAL
Intervention: benfluorex (150 mg x 3 daily)
Number of subjects: 32
Study 8887014 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study 2005918 — intervention group
Group type: EXPERIMENTAL
Intervention: TGLVP (5.0, 7.5, or 10.0 micrograms/kg of body weight)
Number of subjects: 7
Study 2005918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2005918 — intervention group
Group type: EXPERIMENTAL
Intervention: TGLVP
Number of subjects: 7
Study 6419593 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin, 3 mg twice daily
Number of subjects: 340
Study 6419593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 31609464 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 111
Study 31609464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 29653569 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 180
Study 29653569 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum laser acupuncture
Number of subjects: 180
Study 29653569 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser acupuncture
Number of subjects: 180
Study 29653569 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture and laser acupuncture
Number of subjects: 180
Study 28158576 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenephrology (web-based consultation)
Number of subjects: 3004
Study 28158576 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 3004
Study 25827597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 121
Study 25827597 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 121
Study 25827597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection diclofenac sodium (75 mg)
Number of subjects: 121
Study 23253958 — intervention group
Group type: EXPERIMENTAL
Intervention: Saw palmetto extract (320 mg for the first 24 weeks, 640 mg for the next 24 weeks, and 960 mg for the last 24 weeks)
Number of subjects: 369
Study 23253958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study 21982622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepitel(®)
Number of subjects: 15
Study 21982622 — intervention group
Group type: COMPARATOR
Intervention: SurfaSoft(®)
Number of subjects: 15
Study 18182539 — intervention group
Group type: EXPERIMENTAL
Intervention: Journey of Hope course (intervention group)
Number of subjects: 462
Study 16675962 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 0
Study 16675962 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrates
Number of subjects: 0
Study 16675962 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin
Number of subjects: 0
Study 16675962 — intervention group
Group type: EXPERIMENTAL
Intervention: PPAR ligands (GW7647, GW0742, GW2433, rosiglitazone, GW4148)
Number of subjects: 0
Study 14985300 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost administered as 1 drop
Number of subjects: 24
Study 10902624 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 1392
Study 10902624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1392
Study 9302882 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure breathing (PPB) after rapid decompression to 72,000 feet
Number of subjects: 6
Study 9302882 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure breathing (PPB) at ground level
Number of subjects: 6
Study 9302882 — intervention group
Group type: EXPERIMENTAL
Intervention: Low oxygen mixtures at ground level
Number of subjects: 6
Study 9302882 — intervention group
Group type: EXPERIMENTAL
Intervention: PPB and low pressure at high altitude
Number of subjects: 6
Study 8342828 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg ITMS
Number of subjects: 20
Study 8342828 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg ITMS
Number of subjects: 20
Study 8342828 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg ITMS
Number of subjects: 20
Study 3790968 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of metoclopramide (7 mg/kg)
Number of subjects: 33
Study 3790968 — intervention group
Group type: COMPARATOR
Intervention: Intermittent infusion of metoclopramide (7 mg/kg)
Number of subjects: 33
Study 29595585 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent prospective memory training
Number of subjects: 25
Study 29595585 — intervention group
Group type: COMPARATOR
Intervention: Control (no contact during training phase)
Number of subjects: 25
Study 27575534 — intervention group
Group type: EXPERIMENTAL
Intervention: Social dancing classes (folk or ballroom dancing) twice weekly for 12 months (80 hours total)
Number of subjects: 530
Study 27575534 — intervention group
Group type: COMPARATOR
Intervention: Control group continued with regular activities
Number of subjects: 530
Study 27575534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballroom dancing
Number of subjects: 530
Study 27575534 — intervention group
Group type: EXPERIMENTAL
Intervention: Folk dancing
Number of subjects: 530
Study 24087940 — intervention group
Group type: EXPERIMENTAL
Intervention: IV iron sucrose therapy
Number of subjects: 11
Study 21924507 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic sunlight exposure
Number of subjects: 30
Study 20843575 — intervention group
Group type: COMPARATOR
Intervention: Peg‐interferon alpha‐2b plus 1000‐1200 mg of ribavirin daily (according to body weight) for 24 weeks (Std24)
Number of subjects: 414
Study 20843575 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus 1000‐1200 mg of ribavirin daily for variable duration of 12 or 36 weeks (Var12/36)
Number of subjects: 414
Study 20843575 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 12 weeks in patients with wk4-R
Number of subjects: 414
Study 20843575 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 36 weeks in patients with wk4-R
Number of subjects: 414
Study 20843575 — intervention group
Group type: COMPARATOR
Intervention: Peg‐interferon alpha‐2b plus ribavirin for 24 weeks in patients without wk4-R
Number of subjects: 414
Study 20843575 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha‐2b plus ribavirin for variable duration in patients without wk4-R
Number of subjects: 414
Study 18389446 — intervention group
Group type: EXPERIMENTAL
Intervention: Back-to-back video colonoscopy
Number of subjects: 294
Study 16983910 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongfu Xiere Recipe (TXR) combined with basic therapy (conventional treatment and antibiotics)
Number of subjects: 89
Study 16983910 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy alone (control group)
Number of subjects: 89
Study 16983910 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongfu Xiere Recipe (TXR) combined with basic therapy
Number of subjects: 89
Study 12713210 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-targeted program
Number of subjects: 60
Study 12713210 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-targeted program
Number of subjects: 60
Study 12713210 — intervention group
Group type: COMPARATOR
Intervention: Comparison intervention (global self-esteem)
Number of subjects: 60
Study 10995404 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 20
Study 10995404 — intervention group
Group type: COMPARATOR
Intervention: Nicardipine
Number of subjects: 20
Study 8648918 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 312
Study 8648918 — intervention group
Group type: COMPARATOR
Intervention: CsA
Number of subjects: 312
Study 1381102 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 36
Study 1381102 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 36
Study 1381102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 6495747 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic secretin (Hoechst) alone
Number of subjects: 11
Study 6495747 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic secretin (Hoechst) + natural CCK
Number of subjects: 11
Study 6495747 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-infusion of synthetic secretin + natural CCK
Number of subjects: 11
Study 31741209 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented circuit training combined with aerobic training (TOCT-AT)
Number of subjects: 26
Study 31741209 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 26
Study 30307640 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete chemo‐mechanical disinfection (CMD) of the root canal system
Number of subjects: 57
Study 30307640 — intervention group
Group type: COMPARATOR
Intervention: Removal of necrotic tissue from the pulp chamber (RNT)
Number of subjects: 57
Study 30307640 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CMD and RNT)
Number of subjects: 57
Study 29408901 — intervention group
Group type: EXPERIMENTAL
Intervention: WHELD intervention
Number of subjects: 847
Study 29408901 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 847
Study 26706397 — intervention group
Group type: EXPERIMENTAL
Intervention: Model training for anterior repair (AR)
Number of subjects: 19
Study 26706397 — intervention group
Group type: EXPERIMENTAL
Intervention: Model training for posterior repair (PR)
Number of subjects: 19
Study 26706397 — intervention group
Group type: EXPERIMENTAL
Intervention: Model training for vaginal hysterectomy (VH)
Number of subjects: 19
Study 26706397 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 19
Study 24522223 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat Back (RB)
Number of subjects: 575
Study 24522223 — intervention group
Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB)
Number of subjects: 575
Study 23290159 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (40 - 80 mg qd)
Number of subjects: 48
Study 23290159 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (5 - 10 mg qd)
Number of subjects: 48
Study 20347404 — intervention group
Group type: EXPERIMENTAL
Intervention: IDet before lunch
Number of subjects: 39
Study 20347404 — intervention group
Group type: COMPARATOR
Intervention: IDet bedtime
Number of subjects: 39
Study 20347404 — intervention group
Group type: COMPARATOR
Intervention: IDet-12h
Number of subjects: 39
Study 19278079 — intervention group
Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices (20% to 65% baking soda)
Number of subjects: 270
Study 19278079 — intervention group
Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices
Number of subjects: 270
Study 19278079 — intervention group
Group type: EXPERIMENTAL
Intervention: Baking soda dentifrices with higher concentrations of baking soda
Number of subjects: 270
Study 19278079 — intervention group
Group type: COMPARATOR
Intervention: Non-baking soda dentifrices
Number of subjects: 270
Study 15766997 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement providing a recommended daily allowance of 15 vitamins and minerals
Number of subjects: 1200
Study 15766997 — intervention group
Group type: COMPARATOR
Intervention: Routine iron and folic acid supplements (control)
Number of subjects: 1200
Study 15766997 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement
Number of subjects: 1200
Study 12648027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketoprofen 1 mg/kg
Number of subjects: 28
Study 12648027 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal ketoprofen 25 mg (dose normalized to 1 mg/kg)
Number of subjects: 28
Study 10716682 — intervention group
Group type: EXPERIMENTAL
Intervention: PMF-100 (250 ml twice daily; PEG 14.6 g twice daily)
Number of subjects: 70
Study 10716682 — intervention group
Group type: EXPERIMENTAL
Intervention: PMF-100
Number of subjects: 70
Study 10716682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 8613657 — intervention group
Group type: COMPARATOR
Intervention: 0 g lactose in water
Number of subjects: 13
Study 8613657 — intervention group
Group type: COMPARATOR
Intervention: 2 g lactose in water
Number of subjects: 13
Study 8613657 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g lactose in water
Number of subjects: 13
Study 8613657 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g lactose in water
Number of subjects: 13
Study 8613657 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g lactose in water
Number of subjects: 13
Study 1359818 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (10 mg) inhaled 10 min before challenge with 4.5% NaCl
Number of subjects: 16
Study 1359818 — intervention group
Group type: COMPARATOR
Intervention: Vehicle inhaled 10 min before challenge with 4.5% NaCl
Number of subjects: 16
Study 4080922 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-drinking group
Number of subjects: 0
Study 4080922 — intervention group
Group type: COMPARATOR
Intervention: Tonic-drinking group
Number of subjects: 0
Study 30215676 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303
Study 30215676 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study 30215676 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 303
Study 26787273 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundoplication in children with neurological impairment (NI)
Number of subjects: 87
Study 26787273 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundoplication in children without neurological impairment (non-NI)
Number of subjects: 87
Study 26787273 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental satisfaction after fundoplication
Number of subjects: 87
Study 24099659 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg) plus low-dose prednisone (5 mg twice daily)
Number of subjects: 331
Study 24099659 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus low-dose prednisone (5 mg twice daily)
Number of subjects: 331
Study 22054915 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored self‐help smoking cessation intervention
Number of subjects: 1284
Study 22054915 — intervention group
Group type: COMPARATOR
Intervention: Standard brochure
Number of subjects: 1284
Study 19691033 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy (6-session manualized intervention)
Number of subjects: 59
Study 19691033 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in parallel to supportive psychotherapy)
Number of subjects: 59
Study 18517044 — intervention group
Group type: EXPERIMENTAL
Intervention: Actillume monitoring for one week
Number of subjects: 44
Study 16043677 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (escalating dose from 25 to 300 mg/d)
Number of subjects: 94
Study 16043677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 12458444 — intervention group
Group type: EXPERIMENTAL
Intervention: MultiHance (0.1 mmol/kg bw)
Number of subjects: 12
Study 12458444 — intervention group
Group type: COMPARATOR
Intervention: Gadovist (0.1 mmol/kg bw)
Number of subjects: 12
Study 11888361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care strategy (initial therapy based on clinical need, included zolmitriptan)
Number of subjects: 835
Study 11888361 — intervention group
Group type: COMPARATOR
Intervention: Stepped care across attacks (first-line therapy with simple combination analgesic escalated to zolmitriptan if inadequate response)
Number of subjects: 835
Study 11888361 — intervention group
Group type: COMPARATOR
Intervention: Stepped care within attacks (first-line therapy with simple combination analgesic escalated to zolmitriptan if inadequate response)
Number of subjects: 835
Study 11888361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care strategy
Number of subjects: 835
Study 9862606 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg daily)
Number of subjects: 635
Study 9862606 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (50-300 mg daily)
Number of subjects: 635
Study 9862606 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 635
Study 9862606 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 635
Study 7621460 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with EMP 280 mg twice a day and suramin 1 g weekly infusions for 6 weeks
Number of subjects: 32
Study 7621460 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with EMP and suramin
Number of subjects: 32
Study 7621460 — intervention group
Group type: COMPARATOR
Intervention: EMP 280 mg alone
Number of subjects: 32
Study 2220259 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant methionyl growth hormone (GH) 0.5-0.6 IU.kg-1.week-1
Number of subjects: 6
Study 2220259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 76797 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐isomer of flupenthixol
Number of subjects: 45
Study 76797 — intervention group
Group type: COMPARATOR
Intervention: beta‐flupenthixol
Number of subjects: 45
Study 76797 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study 6353923 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin solution
Number of subjects: 128
Study 6353923 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephapirin solution
Number of subjects: 128
Study 6353923 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 128
Study 29730000 — intervention group
Group type: EXPERIMENTAL
Intervention: Freitod (free death)
Number of subjects: 451
Study 29730000 — intervention group
Group type: EXPERIMENTAL
Intervention: Suizid (suicide)
Number of subjects: 451
Study 29730000 — intervention group
Group type: EXPERIMENTAL
Intervention: Selbstmord (self-murder)
Number of subjects: 451
Study 26651376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Physical Therapy (PT) program, 12.4 ± 6.5 sessions for a total of 408 ± 261 minutes
Number of subjects: 120
Study 26651376 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care PT program, 6.1 ± 3.8 sessions for 86 ± 63 minutes
Number of subjects: 120
Study 24232665 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart music
Number of subjects: 12
Study 24232665 — intervention group
Group type: EXPERIMENTAL
Intervention: Bach music
Number of subjects: 12
Study 24232665 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 12
Study 23102175 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-delivered DASH meals
Number of subjects: 298
Study 23102175 — intervention group
Group type: COMPARATOR
Intervention: Control group (no meals)
Number of subjects: 298
Study 19764973 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin treatment followed by alarm treatment after 3 months
Number of subjects: 43
Study 19764973 — intervention group
Group type: COMPARATOR
Intervention: Alarm treatment followed by desmopressin after 3 months
Number of subjects: 43
Study 19764973 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (both groups)
Number of subjects: 43